These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32522054)

  • 1. Method Development and Application of an Accelerated Solution Stability Screen for Drug Discovery.
    Gomez-Sanchez R; Besley S; Zeliku Z; Young RJ
    SLAS Discov; 2020 Dec; 25(10):1191-1196. PubMed ID: 32522054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.
    Ekert JE; Deakyne J; Pribul-Allen P; Terry R; Schofield C; Jeong CG; Storey J; Mohamet L; Francis J; Naidoo A; Amador A; Klein JL; Rowan W
    SLAS Discov; 2020 Dec; 25(10):1174-1190. PubMed ID: 32495689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of an automated solution stability assay for drug discovery.
    Di L; Kerns EH; Chen H; Petusky SL
    J Biomol Screen; 2006 Feb; 11(1):40-7. PubMed ID: 16234336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System.
    Greenhough LA; Clarke G; Phillipou AN; Mazani F; Karamshi B; Rowe S; Rowland P; Messenger C; Haslam CP; Bingham RP; Craggs PD
    SLAS Discov; 2021 Jun; 26(5):663-675. PubMed ID: 33783261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NanoStore: a concept for logistical improvements of compound handling in high-throughput screening.
    Benson N; Boyd HF; Everett JR; Fries J; Gribbon P; Haque N; Henco K; Jessen T; Martin WH; Mathewson TJ; Sharp RE; Spencer RW; Stuhmeier F; Wallace MS; Winkler D
    J Biomol Screen; 2005 Sep; 10(6):573-80. PubMed ID: 16103412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
    Ding X; Ghobarah H; Zhang X; Jaochico A; Liu X; Deshmukh G; Liederer BM; Hop CE; Dean B
    Rapid Commun Mass Spectrom; 2013 Feb; 27(3):401-8. PubMed ID: 23280971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-throughput Screening Technology for Selective Inhibitors of Transporters and Its Application in Drug Discovery].
    Motoyaji T
    Yakugaku Zasshi; 2021; 141(4):511-515. PubMed ID: 33790118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery.
    Simon RP; Häbe TT; Ries R; Winter M; Wang Y; Fernández-Montalván A; Bischoff D; Runge F; Reindl W; Luippold AH; Büttner FH
    SLAS Discov; 2021 Sep; 26(8):961-973. PubMed ID: 34308708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
    Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
    J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
    Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
    Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free high-throughput screening via mass spectrometry: a single cystathionine quantitative method for multiple applications.
    Holt TG; Choi BK; Geoghagen NS; Jensen KK; Luo Q; LaMarr WA; Makara GM; Malkowitz L; Ozbal CC; Xiong Y; Dufresne C; Luo MJ
    Assay Drug Dev Technol; 2009 Oct; 7(5):495-506. PubMed ID: 19715455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of dacarbazine in aqueous solution.
    Shetty BV; Schowen RL; Slavik M; Riley CM
    J Pharm Biomed Anal; 1992 Sep; 10(9):675-83. PubMed ID: 1286132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemical oxidation coupled with liquid chromatography and mass spectrometry to study the oxidative stability of active pharmaceutical ingredients in solution: A comparison of off-line and on-line approaches.
    Torres S; Brown R; Zelesky T; Scrivens G; Szucs R; Hawkins JM; Taylor MR
    J Pharm Biomed Anal; 2016 Nov; 131():71-79. PubMed ID: 27526403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-driven drug discovery for development of herbal medicine.
    Zhang A; Sun H; Wang X
    Mass Spectrom Rev; 2018 May; 37(3):307-320. PubMed ID: 28009933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery.
    Saurina J; Sentellas S
    Expert Opin Drug Discov; 2019 May; 14(5):469-483. PubMed ID: 30810397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining a High-Quality Screening Collection: The GSK Experience.
    Gomez-Sanchez R; Besley S; Quayle J; Green J; Warren-Godkin N; Areri I; Zeliku Z
    SLAS Discov; 2021 Sep; 26(8):1065-1070. PubMed ID: 34142592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.